Fixed-Dose Combination Inhalers. - Wikidata - awgldk - TriplyDB

Fixed-Dose Combination Inhalers.

Fixed-Dose Combination Inhalers.

http://www.wikidata.org/entity/Q51122644

about

Fixed-Dose Combination Inhalers.

http://www.wikidata.org/entity/Q51122644

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Fixed-Dose Combination Inhalers.

@en

Fixed-Dose Combination Inhalers.

@nl

type

label

Fixed-Dose Combination Inhalers.

@en

Fixed-Dose Combination Inhalers.

@nl

prefLabel

Fixed-Dose Combination Inhalers.

@en

Fixed-Dose Combination Inhalers.

@nl

P1433

Q51122644-12C7BAA0-A35E-476E-9F33-15C35C48C629

P1476

Q51122644-4CA17397-CD7F-4EB9-96AD-BDAB134392A7

P2093

Q51122644-8D75074D-ABC2-481E-AB47-1D6A6AA13254

Q51122644-D49E15F3-0561-49DD-A6F4-DB6420049370

P2860

Q51122644-0282CE74-6A8B-4749-8370-5862B030479E

Q51122644-039E1AC5-1FDB-482C-98B1-91EA1B8FFB56

Q51122644-0C45E4CB-133D-442C-AA56-E73E8371C65D

Q51122644-1142B7A7-2F6F-49BB-BBD6-A456E4D4F7E3

Q51122644-1491EDF2-B3E2-4763-A351-A7336D1A50AC

Q51122644-19E9855D-E4EA-4C5B-BF07-805B0469A787

Q51122644-1B137822-678A-4F17-8D47-8D620C33161A

Q51122644-1E5D5A0D-CE5F-429E-9F0C-AA6B5F5FF5B2

Q51122644-1E784A4D-4F14-4038-BDB2-23988CC48861

Q51122644-2712A53B-3BF1-4C13-83C2-5E06F3CECA75

P304

Q51122644-A9008167-C6ED-4981-AD86-DAA3068773B3

P31

Q51122644-603768B2-0E04-452E-B638-D0CE23F98DA8

P356

Q51122644-B851EDE9-2CC7-4EA6-AB2C-4E32F98E2064

P478

Q51122644-B98A7529-397A-4627-93B8-91190F18E26A

P577

Q51122644-3BEBA4D5-E874-4B8E-945F-F58F783DE110

P698

Q51122644-6A1578A6-78DD-46D6-8175-4A8247C3D4B8

P356

P1433

Handbook of experimental pharmacology

P1476

Fixed-Dose Combination Inhalers.

@en

P2093

Maria Gabriella Matera

http://www.w3.org/2001/XMLSchema#string

Mario Cazzola

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data.

Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis

Tiotropium Respimat® in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma.

Crosstalk between beta-2-adrenoceptor and muscarinic acetylcholine receptors in the airway

Efficacy and safety of combining olodaterol Respimat(®) and tiotropium HandiHaler(®) in patients with COPD: results of two randomized, double-blind, active-controlled studies.

Tiotropium bromide step-up therapy for adults with uncontrolled asthma

Fixed-dose combinations improve medication compliance: a meta-analysis.

Glucocorticosteroids: current and future directions.

P304

117-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/164_2016_66

http://www.w3.org/2001/XMLSchema#string

P478

237

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27783268

http://www.w3.org/2001/XMLSchema#string